OBJECTIVES: Surgical outcomes of patients with functional single ventricle have improved, though those for patients whose condition is complicated by extracardiac type total anomalous pulmonary venous connection (TAPVC) remain poor. We retrospectively reviewed our 21 years of surgical experiences with this challenging group.
INTRODUCTION
Surgical outcomes of patients with functional single ventricle have greatly improved over the past three decades [1, 2] . However, the coexistence of total anomalous pulmonary venous connection (TAPVC) makes treatment complicated [3] [4] [5] [6] [7] . TAPVC was frequently associated with visceral heterotaxy syndrome, particularly right atrial isomerism [8] [9] [10] [11] [12] [13] [14] [15] . Whereas the reasons for higher morbidities and mortalities in patients with right atrial isomerism are thought to be multifactorial [10, 16, 17] , right atrial isomerism with extracardiac TAPVC is a significant risk factor for survival and Fontan completion [6-8, 10, 13-15] . The anatomical feature of extracardiac TAPVC in right atrial isomerism is clearly different from isolated TAPVC. Anomalous positioning of pectoral structures, such as systemic veins, great arteries and even bronchi, is common and varied, which can easily cause kinking and/or distortion in the pulmonary venous drainage pathway. As a result, preoperative pulmonary venous obstruction (PVO) is common [10, 13, 14] . In addition, unusual morphology of atria and pulmonary venous drainage system is another property seen in this group.
Recently, new treatments have been applied to these patients, such as stent implantation for obstructive drainage veins and sutureless marsupialization for relief of postoperative pulmonary venous stenosis (PVS), or even as primary repair of TAPVC [18] [19] [20] [21] . In this study, we retrospectively reviewed our surgical experiences of functional single ventricle with extracardiac TAPVC to reveal the long-term clinical results and also to estimate the efficacy of the present treatment methods.
MATERIALS AND METHODS

Patients
The National Cerebral and Cardiovascular Center Institutional Review Board approved the study and waived the need to obtain patient consent. From 1990 to 2010, 48 consecutive patients with functional single ventricle and extracardiac TAPVC underwent initial surgical palliation at our centre (Table 1) . Forty six of 48 (95.8%) patients were associated with right atrial isomerism. For patients with right atrial isomerism, 180 underwent initial surgical intervention during the same period. Thirteen patients who underwent or attempted biventricular repair were excluded from this study. Of the remaining 167 patients, TAPVC was associated with 93 (55.7%); of these, 43 with cardiac type TAPVC and 2 with mixed type TAPVC including cardiac type TAPVC were also excluded. The median age and body weight at initial surgery were 69 days and 3.5 kg, respectively. Anomalous systemic venous drainage pathway was presented in 32 (66.7%) patients. The type of TAPVC was supracardiac in 31 patients, infracardiac in 14 and mixed type (without cardiac type TAPVC) in 3.
Timing and methods of TAPVC repair
Obstructive pulmonary venous drainage pathways were found to coexist in 28 (58.3%) patients (Fig. 1) . Excluding 1 patient before the repair of TAPVC, 25 out of 27 patients underwent repair of TAPVC before bidirectional Glenn (BDG) in the neonatal or early infantile period. Since 2007, stent implantation for obstructive drainage veins has been a treatment option if anatomical conditions allowed and the remaining 2 patients underwent it [18] . Including these 2 stent cases, 18 patients underwent repair of TAPVC at the timing of BDG. One patient underwent TAPVC repair concomitant with a primary Fontan operation. TAPVC remained in 2 patients.
Surgical repair of TAPVC was performed with the common pulmonary venous chamber and atrium anastomosis under cardiac arrest. Total circulatory arrest was not applied in any case over this study period. The vertical vein was ligated and divided in all cases.
Study methods and statistical analysis
From medical records, we retrospectively investigated the following values: (i) overall survival rate, (ii) risk factors for survival, (iii) comparison of clinical outcome of patients who underwent the repair of TAPVC before BDG and at BDG, (iv) incidence of postoperative PVS, (v) impact of postoperative PVS on survival and Fontan completion, (vi) comparison of survival rate by surgical era and (vii) current status of patients with a completed Fontan operation.
The data are expressed as mean ± standard deviation or as median (range) as appropriate. The data were analysed with SPSS (SPSS, Inc., Chicago, IL, USA). Survival probabilities and freedom from postoperative PVS rate were evaluated by the Kaplan-Meier method. Cox proportional hazard models are used to analyse risk factors for survival. The Mann-Whitney U-test was used to compare continuous variables, and the χ 2 test was used to compare categorical data between the two groups. Differences were considered statistically significant if the P-value was <0.05.
RESULTS
Impact of the timing of TAPVC repair
Regarding the timing of the repair of TAPVC, clinical outcomes are summarized in Fig. 1 . At first, surgical intervention of 1 patient with PVO was declined by the parents after coarctation repair concomitant with pulmonary artery banding and therefore dropped out of further treatment. Another patient without PVO was transferred to a different hospital after a systemic to pulmonary shunt.
Of 25 patients in the neonatal or early infantile period who underwent repair of TAPVC before BDG because of coexisting preoperative PVO, 16 expired without undergoing the next stage of BDG (16 of 27 = 59.3%). Excluding a patient who dropped out but is still alive, yet cannot proceed to BDG owing to pulmonary hypertension, 7 underwent BDG with only 1 surviving to Fontan completion. With 1 patient who underwent a Fontan operation primarily without pre-stage BDG, only 2 proceeded to the Fontan operation, so the probability of Fontan completion in patients undergoing TAPVC repair before BDG was 8.0% (2 of 25).
On the other hand, 16 patients without preoperative PVO and 2 who previously underwent stent implantation for obstructive drainage vein had repair of TAPVC concomitant with BDG. Of those, 11 patients proceeded to a Fontan operation. Thus, the probability of Fontan completion in patients undergoing TAPVC repair concomitant with BDG was 61.1% (11 of 18), which is significantly better than that seen in patients undergoing TAPVC repair before BDG (P = 0.0002, odds ratio: 0.055, 95% confidence interval: 0.010-0.311).
In addition, 3 patients without PVO also underwent Fontan operations without TAPVC repair until the Fontan operation. Of those, 1 patient underwent a Fontan operation concomitant with TAPVC repair, following a systemic to pulmonary shunt. TAPVC remained in the other 2 patients with supracardiac TAPVC by division of superior vena cava to lead the pulmonary venous blood flow drain into the atrium.
Over the study period, the cumulative survival rate did not improve over time. Stent implantation for obstructive drainage veins and sutureless marsupialization as relief of postoperative PVS have been initiated since 2007; however, the effect is still limited (log rank: P = 0.058; Fig. 2 ).
Overall outcomes
Overall survival rates at 1, 3 and 5 years were 58.3, 41.1 and 31.3%, respectively (Fig. 3) . Presently, 16 of the 48 patients achieved Fontan completion (33.3%). Univariate analysis revealed that coexisting pulmonary atresia with major aortopulmonary colateral arteries, TAPVC repair before BDG and infracardiac TAPVC were risk factors for survival. The presence of postoperative PVS, pulmonary valve atresia and pulmonary valve stenosis were not detected as risk factors. Multivariable analysis detected TAPVC repair before BDG as an only risk factor for survival (P = 0.032; Table 2 ). The mean follow-up period was 4.2 ± 5.1 years. Follow-up was completed in 98% of patients.
Postoperative PVS
The freedom from postoperative PVS rates at 1 and 3 years after repair was 68.7 and 63.4%, respectively (Fig. 4) . Eleven patients developed postoperative PVS ( Table 3 ). The surgical methods used for the relief of postoperative PVS were cutback of stenotic orifice in 6 patients, and re-anastomosis between obstructive pulmonary vein and atrium in 2. Sutureless marsupialization has been applied since 2007 and 3 patients underwent it. If present, proliferated intimal tissue was removed as much as possible in all cases. Although postoperative PVS was not a risk factor for survival, none of these 11 patients achieved a Fontan operation, excepting one, who developed protein-losing enteropathy, and has needed a long hospitalization.
Clinical status of patients undergoing a Fontan operation
Demographics of patients undergoing Fontan completion were summarized in Table 4 . There were 3 in-hospital mortalities. One patient underwent takedown to BDG due to gastrointestinal bleeding, junctional tachycardia caused by the presence of twin atrioventricular nodes and subsequent repeated thrombotic embolization in the extracardiac conduit. Another 3 patients developed protein-losing enteropathy. One patient who developed severe congestive heart failure underwent common atrioventricular valve replacement and cardiac resynchronization therapy without a clear response. 
COMMENT
This study demonstrated that the survival of patients with functional single ventricle and obstructive extracardiac TAPVC still remains poor. The probability of Fontan completion was significantly lower in patients who underwent repair of TAPVC before BDG, compared with those at the timing of BDG, because of the presence of preoperative PVO. Postoperative PVS was not a risk factor for mortality, though it was a significant risk factor for Fontan completion. Stent implantation for obstructive drainage veins and sutureless marsupialization as relief of postoperative PVS seem to be an optimal alternative approach; however, it has not been seen to improve overall outcomes so far.
As several institutions have reported, the outcome of patients with functional single ventricle requiring the repair of extracardiac TAPVC at the neonatal or early infantile periods was poor [3, 8, [13] [14] [15] . The necessity of early repair of extracardiac TAPVC before BDG anastomosis indicates coexisting obstruction of pulmonary venous drainage pathways. In this study, however, the presence of preoperative PVO did not reduce survival, based on the survival of 2 patients with preoperative obstructive drainage veins who underwent stent implantation. Therefore, if a native pulmonary venous vascular anomaly is not associated, and if PVO is mainly caused by stenosis of drainage veins, stent implantation for obstructive drainage veins might be an alternative approach to avoid early TAPVC repair. Delaying the timing of repair of TAPVC is not a goal in managing this challenging group, but the subsequent repair of TAPVC after physical growth following stenting may contribute to reducing the risk of kinking or distortion of the anastomosis part, because the repair of TAPVC in the neonatal period tends to be complicated more by secondary PVS, probably in part due to distortion and/or excess intimal proliferation at the anastomosis site.
Whereas postoperative PVS was not associated with life prognosis, it was a significant risk factor for achieving a Fontan operation. Recurrent PVS was usually common after conventional relief methods, such as intimal resection or orifice cutback. Whereas undelayed and aggressive interventions for stenotic veins with sutureless marsupialization may improve the outcomes of patients requiring early repair of TAPVC, complete obstruction or tubular stenosis beyond hilar was out of this indication. Therefore, once postoperative PVS occurs, elevated pulmonary vascular resistance tends to remain high for Fontan operations. Recently, a few studies reported the efficacy of primary sutureless marsupialization for this anatomical subset [19] [20] [21] .
As with other reports [6, 7] , the vast majority of patients in this study, 95.8%, were associated with right atrial isomerism. Even though statistical risk analysis did not identify any risk factors for survival except early repair of TAPVC, patients with right atrial isomerism are well known to have risks of infections, end-organ complications, respiratory complications, common atrioventricular valve regurgitation and arrhythmia, which should affect the mortality and morbidity during and after the successful performance of surgery [10, 16, 17] . Indeed, the early-and mid-term outcomes of patients undergoing Fontan operations are still unsatisfactory in this series, as opposed to other reports [12] . About half of the patients developed mortality or clinically significant morbidity such as heart failure and protein-losing enteropathy. Sinus rhythm was rarely maintained. Common atrioventricular valve replacement is frequently required even after ventricular volume unloading after a Fontan operation. Regarding quality of life, it might be better for some patients to undergo BDG with additional pulmonary blood flow as a destination surgery, as the Texas group implemented [12] .
Study limitations
Because this is a retrospective and long-term study over >20 years, it is difficult to draw any firm conclusions as the treatments have evolved. Indeed, we expect the effect of stenting of preoperative obstructive pulmonary venous drainage pathway and sutureless marsupialization for postoperative PVS, but cannot show the statistically significant improvement of overall outcomes. The other limitation is that we focused on the management of associated extracardiac TAPVC, so other specific issues related to the single ventricular physiology such as the regulation of pulmonary blood flow, preservation of systemic ventricular function and also atrioventricular function were not discussed. However, it was a fact that preoperative PVO and postsurgical PVS strongly affected the survival and quality of life of patients in this challenging anatomical group, thus, we are determined to keep trying new approaches, including the primary sutureless technique, in the near future, and verifying the results.
CONCLUSION
Surgical outcomes of patients with functionally single ventricles necessitating the repair of extracardiac TAPVs in the neonatal period due to obstruction of the venous drainage pathways remain poor, though gradual improvement was seen in recent cases. Stent implantation for obstructive drainage veins to delay the timing of surgical correction and sutureless marsupialization as relief of postoperative PVS seemed to contribute to the improvement of the outcomes in patients with preoperative PVO; however, the effect is still limited. Postoperative PVS was a significant risk factor for achieving a Fontan operation, thus the sutureless marsupialization technique could be expected to improve later outcomes.
